Guaifenesin
NDC 11822-4260, Guaifenesin, tablet, extended release, from RITE AID CORPORATION.
- Product NDC
- 11822-4260
- Status
- Listed
- Labeler
- RITE AID CORPORATION
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA210453
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11822-4260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN1200 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11822-4260-1 | 11822426001 | 1 BLISTER PACK in 1 CARTON (11822-4260-1) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| 11822-4260-2 | 11822426002 | 2 BLISTER PACK in 1 CARTON (11822-4260-2) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| 11822-4260-3 | 11822426003 | 3 BLISTER PACK in 1 CARTON (11822-4260-3) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11822-4260 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11822-4260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11822-4260. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.